ESMO Clinical Practice Guidelines: Genitourinary Cancers
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Urogenital Cancers: Prostate cancer, Bladder cancer, Renal cell cancer (RCC) Penile cancer and Testicular seminoma and non-seminoma. They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Bladder Cancer: ESMO Clinical Practice Guidelines
Published in 2014 – Ann Oncol (2014) doi: 10.1093/annonc/mdu223 First published online: August 5, 2014
Authors: J. Bellmunt, A. Orsola, J. J. Leow, T. Wiegel, M. De Santis, A. Horwich
Prostate Cancer: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi106-vi114.
Authors: A. Horwich, C. Parker, T. de Reijke, V. Kataja
Penile Carcinoma: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi115-vi124.
Authors: H. Van Poppel, N. A. Watkin, S. Osanto, L. Moonen, A. Horwich, V. Kataja
Testicular Seminoma and Non-Seminoma: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi125-vi132.
Authors: J. Oldenburg, S. D. Fosså, J. Nuver, A. Heidenreich, H-J Schmoll, C. Bokemeyer, A. Horwich, J. Beyer, V. Kataja
Renal Cell Carcinoma: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii65-vii71.
Authors: B. Escudier, T. Eisen, C. Porta, J. J. Patard, V. Khoo, F. Algaba, P. Mulders, V. Kataja